blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3738601

EP3738601 - CYTOCIDAL AGENT [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  20.10.2023
Database last updated on 16.09.2024
FormerRequest for examination was made
Status updated on  16.10.2020
FormerThe international publication has been made
Status updated on  02.03.2019
Most recent event   Tooltip02.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Fujita Academy
1-98 Dengakugakubo
Kutsukake-cho
Toyoake-shi, Aichi 470-1192 / JP
[2020/47]
Inventor(s)01 / SUGIHARA Kazuhiro
c/o National University Corporation Hamamatsu
University School of Medicine
20-1 Handayama 1-chome
Higashi-ku
Hamamatsu-shi Shizuoka 431-3192 / JP
02 / KANAYAMA Naohiro
c/o National University Corporation Hamamatsu
University School of Medicine
20-1 Handayama 1-chome
Higashi-ku
Hamamatsu-shi Shizuoka 431-3192 / JP
03 / ONODERA Yuichiro
c/o National University Corporation Hamamatsu
University School of Medicine
20-1 Handayama 1-chome
Higashi-ku
Hamamatsu-shi Shizuoka 431-3192 / JP
04 / SHIBATA Toshiaki
c/o National University Corporation Hamamatsu
University School of Medicine
20-1 Handayama 1-chome
Higashi-ku
Hamamatsu-shi Shizuoka 431-3192 / JP
05 / FUKUDA Michiko
c/o NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL
SCIENCE AND TECHNOLOGY
Tsukuba Central 1
1-1 Umezono 1-chome
Tsukuba-shi Ibaraki 305-8560 / JP
06 / NONAKA Motohiro
c/o NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL
SCIENCE AND TECHNOLOGY
Tsukuba Central 1
1-1 Umezono 1-chome
Tsukuba-shi Ibaraki 305-8560 / JP
 [2020/47]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2020/47]
Application number, filing date18848077.623.08.2018
[2020/47]
WO2018JP31136
Priority number, dateJP2017016155624.08.2017         Original published format: JP 2017161556
[2020/47]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019039540
Date:28.02.2019
Language:JA
[2019/09]
Type: A1 Application with search report 
No.:EP3738601
Date:18.11.2020
Language:EN
[2020/47]
Search report(s)International search report - published on:JP28.02.2019
(Supplementary) European search report - dispatched on:EP17.05.2021
ClassificationIPC:A61K38/10, A01K67/027, A61K47/66, A61P15/00, A61P35/00, A61P43/00, C07K7/08, C07K19/00
[2020/47]
CPC:
A61K38/10 (EP,KR,US); A01K67/027 (EP,KR); A61K47/66 (KR,US);
A61P15/00 (EP); A61P15/02 (KR); A61P35/00 (EP,KR,US);
A61P43/00 (EP); G01N33/6893 (KR,US); C07K19/00 (EP);
C07K7/08 (EP); G01N2800/364 (KR,US); G01N2800/50 (KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/47]
TitleGerman:ZELLZERSTÖRENDES MITTEL[2020/47]
English:CYTOCIDAL AGENT[2020/47]
French:AGENT CYTOCIDE[2020/47]
Entry into regional phase25.02.2020Translation filed 
25.02.2020National basic fee paid 
25.02.2020Search fee paid 
25.02.2020Designation fee(s) paid 
25.02.2020Examination fee paid 
Examination procedure09.01.2019Request for preliminary examination filed
International Preliminary Examining Authority: JP
25.02.2020Examination requested  [2020/47]
17.11.2021Amendment by applicant (claims and/or description)
20.10.2023Despatch of a communication from the examining division (Time limit: M04)
19.02.2024Reply to a communication from the examining division
Fees paidRenewal fee
25.08.2020Renewal fee patent year 03
06.08.2021Renewal fee patent year 04
29.07.2022Renewal fee patent year 05
21.08.2023Renewal fee patent year 06
01.08.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2007076501  (BURNHAM INST MEDICAL RESEARCH [US], et al) [Y] 1-15 * abstract * * page 1, line 10 - page 33, line 14 * * example - * * claim - * * sequence 1 *;
 [XYI]WO2011027312  (KONINKL PHILIPS ELECTRONICS NV [NL], et al) [X] 15 * abstract * * page 1, line 1 - page 123, line 15 * * example - * * claim - * [Y] 15 [I] 15;
 [Y]WO2011079304  (SANFORD BURNHAM MED RES INST [US], et al) [Y] 1-15 * abstract * * page 1, paragraph 4 - page 66, paragraph 2 * * example - * * claim - ** sequence 2 *;
 [XYI]WO2014201118  (SANFORD BURNHAM MED RES INST [US], et al) [X] 1-15 * abstract * * page 1, line 12 - page 55, line 18 * * example - * * claim - * * sequences 1-4 * [Y] 1-15 [I] 1-15;
 [XYI]  - S. HATAKEYAMA ET AL, "Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20111206), vol. 108, no. 49, doi:10.1073/pnas.1105057108, ISSN 0027-8424, pages 19587 - 19592, XP055040103 [X] 1-9 * abstract * * page 19587, column l, paragraph 1 - page 19591, column r, paragraph 3 * [Y] 1-9 [I] 1-9

DOI:   http://dx.doi.org/10.1073/pnas.1105057108
 [XYI]  - K. SUGIHARA ET AL, "Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis", NATURE COMMUNICATIONS, GB, (20140622), vol. 5, doi:10.1038/ncomms5478, ISSN 2041-1723, XP055255332 [X] 1-9 * abstract * * page 2, column l, paragraph 1 - page 8, column r, paragraph 4 * [Y] 1-9 [I] 1-9

DOI:   http://dx.doi.org/10.1038/ncomms5478
International search[Y]JP2013523824  [Y] 11-17 * , *;
 [Y]WO2015041019  (UNIV KYOTO [JP], et al) [Y] 10 * , *;
 [XY]US2016145308  (FUKUDA MICHIKO [US], et al) [X] 1-7 * , 3, 4, 6, 8, 5, 6 1, 77, 93, 109, 125, 141,157, 0041, 0 051, 0140, 0153, 0154, 0159, 0184, 0 191, 0220, 0263, 3 * [Y] 5, 8-17;
 [Y]  - SUGIHARA, Kazuhiro et al, "Search of peptide therapeutic drugs for endometriosis", Programs and abstracts of the 32nd Annual Meeting of the Japan Society of Drug Delivery System, (20160000), page 170, XP009519434 [Y] 8, 9
 [Y]  - SHIBATA, Toshiaki et al, "P3-14-1 Anti-tumor drugs using peptide that mimics sugar chains", Acta Obstetrica et Gynaecologica Japonica, (20160000), vol. 68, no. 2, ISSN 0300-9165, page 858, XP009519433 [Y] 5
 [A]  - SUGIHARA, K. et al., "Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis", NATURE COMMUNICATIONS, (20140000), vol. 5, no. 4478, doi:10.1038/ncomms5478, ISSN 2041-1723, pages 1 - 9, XP055255332 [A] 1-17

DOI:   http://dx.doi.org/10.1038/ncomms5478
by applicantUS2016145308
 JP2017161556
    - SUGIHARA et al., NATURE COMMUNICATIONS, (20140000), vol. 5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.